Key facts
- Notable investors include Jolmo Investment, Lianyungang Jinhai Venture Capital, Longwater Investment, Shanghai Realpa Machinery, Tenyall Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for HuiHeHuaDe
- ·The full record, as it builds
Funding rounds
No funding rounds for HuiHeHuaDe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HuiHeHuaDe
Provider and developer of biotechnology intend to serve the medical industry. The company is mainly focused on technology promotion and application service in the medical industry, providing clients with new materials needed in the medical and clinical industry.
- Sector
- Business Products and Services (B2B)
- HQ
- Shanghai, China
- Founded
- 2015
- Employees
- 17
- Website
- hybrid-chem.com/
- Ownership
- Privately Held (backing)
HuiHeHuaDe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HuiHeHuaDe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HuiHeHuaDe in its N-PORT filings yet. We sweep new filings monthly.